2022 annual financial data
Neumora Therapeutics 2022 Net income growth
Direct answer
Net income growth was 44.84%.
Operating income was -135,870,000 USD and net income was -130,904,000 USD.
Operating cash flow was -114,896,000 USD.
Get free Neumora Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -135,870,000 USD
- Net income
- -130,904,000 USD
- Operating cash flow
- -114,896,000 USD